SZT2
protein-codingSZT2 subunit of KICSTOR complex, the group of MicroRNA protein coding host genes|KICSTOR complex
Gene summary
The protein encoded by this gene is expressed in the brain, predominantly in the parietal and frontal cortex as well as in dorsal root ganglia. It is localized to the peroxisome, and is implicated in resistance to oxidative stress. It likely functions by increasing superoxide dismutase (SOD) activity, but itself has no direct SOD activity. Studies in mice show that this gene confers low seizure threshold, and may also enhance epileptogenesis. [provided by RefSeq, Jun 2011]
- C1orf84
- KIAA0467
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~64.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014201
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0014201
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0014201
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0014201
Submitter: Illumina
Inheritance Pattern: AR
Disease ID:MONDO:0014201
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0018614
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0100062
Submitter: ClinGen
The *SZT2* gene was first identified in 2009 in mice with reduced seizure threshold (Frankel et al., PMID:19624305). Later, in 2013, Basel-Vanagaite et al reported biallelic variants in patients with infantile encephalopathy with epilepsy and dysmorphic corpus callosum (PMID:23932106). More recently, *SZT2* was revealed to play an important role in a novel protein complex called KICSTOR, a negative regulator of the mTOR pathway. Variants in SZT2 may lead to elevated mTorc1 signaling (PMIDs:28199306, 28199315). Clinical features in individuals with biallelic variants in *SZT2* include infantile- to early-onset epilepsy (onset within 1 day to 10 years), intellectual disability, developmental delay, macrocephaly with dysmorphic facial features, dysmorphic corpus callosum and dysregulated cortical migration. At least 13 unique variants reported in 7 probands were included in this curation (PMIDs: 23932106, 27248490, 28556953, 29696782, 30818181). More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. This gene-disease relationship is also supported by experimental evidence including a mouse model (PMID:19624305). In summary, *SZT2* is definitively associated with autosomal recessive developmental and epileptic encephalopathy. This classification was approved by the Epilepsy Gene Curation Expert Panel on 02/02/2021 (SOP version 8).
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: As with other conditions involving seizures, optimal seizure control is beneficial, and awareness of genetic causes may help with medication selection
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SZT2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001365999.1. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 20 | 915 | 2 | 937 | ||
| missense | 7 | 10 | 1575 | 74 | 5 | 1671 |
| nonsense | 44 | 24 | 1 | 69 | ||
| start loss | 0 | |||||
| frameshift | 62 | 15 | 5 | 82 | ||
| splice donor/acceptor (+/-2bp) | 3 | 36 | 14 | 1 | 54 | |
| Total | 116 | 85 | 1615 | 990 | 7 | 2813 |
Highest pathogenic variant AF is 0.000047088623
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001352928.1 | 72 | MANE Select | |
| Ensembl | ENSP00000489255.1 | 72 | MANE Select | |
| RefSeq | NP_056099.3 | 71 | Standard | |
| Ensembl | ENSP00000361528.4 | 5 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- central nervous system development
- post-embryonic development
- corpus callosum morphogenesis
- cellular response to amino acid starvation
- cellular response to glucose starvation
Molecular Function
- molecular_function
- protein binding
Cellular Component
- lysosomal membrane
- peroxisome
- GATOR2 complex
- KICSTOR complex
- GATOR1 complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000562955
- Coding exons
- 71
- Length
- 62769
- Individuals with no LoFs
- 125598
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 150
- Defined
- 125748
- p
- 0.000597
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.60 | 1666 | 1.99e+3 | 0.836 | 0.000126 | 21596 |
| Missense (PolyPhen) | 719 | 957.36 | 0.75102 | 10436 | ||
| Synonymous | 0.228 | 768 | 776 | 0.990 | 0.0000437 | 7211 |
| Loss of Function | 8.52 | 61 | 187 | 0.327 | 0.0000117 | 1842 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00064 | 0.00062 | rare |
| Latino/Admixed American | 0.00029 | 0.00029 | rare |
| Ashkenazi Jewish | 0.00022 | 0.00020 | rare |
| East Asian | 0.00088 | 0.00087 | rare |
| Finnish | 0.00031 | 0.00023 | rare |
| European (Non-Finnish) | 0.00069 | 0.00067 | rare |
| South Asian | 0.0010 | 0.0010 | notable |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: As part of the KICSTOR complex functions in the amino acid-sensing branch of the TORC1 signaling pathway. Recruits, in an amino acid-independent manner, the GATOR1 complex to the lysosomal membranes and allows its interaction with GATOR2 and the RAG GTPases. Functions upstream of the RAG GTPases and is required to negatively regulate mTORC1 signaling in absence of amino acids. In absence of the KICSTOR complex mTORC1 is constitutively localized to the lysosome and activated. The KICSTOR complex is also probably involved in the regulation of mTORC1 by glucose (PubMed:28199306, PubMed:28199315). May play a role in the cellular response to oxidative stress (By similarity). {ECO:0000250|UniProtKB:A2A9C3, ECO:0000269|PubMed:28199306, ECO:0000269|PubMed:28199315}.;
Recessive Scores
- pRec
- 0.0920
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.114
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |